Association of Progressive PPFE and Mortality in Lung Cancer Screening Cohorts

• URL: http://arxiv.org/abs/2603.09531v2
• Date: Tue, 17 Mar 2026 14:06:33 GMT
• Title: Association of Progressive PPFE and Mortality in Lung Cancer Screening Cohorts
• Abstract summary: Pleuroparenchymalfibroelastosis (PPFE) is an upper predominantfibrotic lung abnormality.<n>The clinical significance of PPFE progression in lung cancer screening populations remains unclear.
• Score: 5.971403380829146
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Background: Pleuroparenchymal fibroelastosis (PPFE) is an upper lobe predominant fibrotic lung abnormality associated with increased mortality in established interstitial lung disease. However, the clinical significance of radiologic PPFE progression in lung cancer screening (LCS) populations remains unclear. Methods: We analysed longitudinal low-dose CT scans and clinical data from two LCS studies: National Lung Screening Trial (NLST; n=7,980); SUMMIT study (n=8,561). An automated algorithm quantified PPFE volume on baseline and follow-up scans. Annualised change in PPFE was derived and dichotomised using a distribution-based threshold to define progressive PPFE. Associations between progressive PPFE and mortality were evaluated using Cox proportional hazards models adjusted for demographic and clinical variables. In SUMMIT cohort, associations between progressive PPFE and clinical outcomes were assessed using incidence rate ratios (IRR) and odds ratios (OR). Findings: Progressive PPFE independently associated with mortality in both LCS cohorts (NLST: Hazard Ratio (HR)=1.25, 95% Confidence Interval (CI): 1.01--1.56, p=0.042; SUMMIT: HR=3.14, 95% CI: 1.66--5.97, p<0.001). Within SUMMIT, progressive PPFE was strongly associated with higher respiratory admissions (IRR=2.79, p<0.001), increased antibiotic and steroid use (IRR=1.55, p=0.010), and showed a trend towards higher modified medical research council scores (OR=1.40, p=0.055). Interpretation: Radiologic PPFE progression independently associates with mortality across two large LCS cohorts, and associates with adverse clinical outcomes. Quantitative assessment of PPFE progression may provide a clinically relevant imaging biomarker to identify individuals at increased risk of respiratory morbidity within LCS programmes.

Related papers

• Optimizing Clinical Trial Protocols Using EHR-Derived Heterogeneous Treatment Effects [6.268930167932179]
  We emulate the DAPA-HF trial using electronic health records from the Mayo Clinic Cloud.<n>In this study, we investigate whether HTE-guided stratification can identify patient subgroups with distinct treatment responses to dapagliflozin.
  arXiv  Detail & Related papers  (2026-07-18T19:06:47Z)
• Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance [69.07885031885303]
  We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model.<n>It outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates.<n>In a multi-center cohort of 6,668 patients from 12 hospitals in China, HCC-STAR achieved state-of-the-art performance in treatment recommendation and risk stratification.
  arXiv  Detail & Related papers  (2026-07-09T15:33:08Z)
• Improving Risk Stratification in Hypertrophic Cardiomyopathy: A Novel Score Combining Echocardiography, Clinical, and Medication Data [0.3611680827515096]
  Hypertrophic cardiomyopathy (HCM) requires accurate risk stratification to inform decisions regarding ICD therapy and follow-up management.<n>This study develops a robust, explainable machine learning (ML) risk score to predict a 5-year composite cardiovascular outcome in HCM patients.<n>The model high interpretability and its capacity for longitudinal risk monitoring represent promising tools for the personalized clinical management of HCM.
  arXiv  Detail & Related papers  (2026-03-27T10:22:46Z)
• Imaging-Based Mortality Prediction in Patients with Systemic Sclerosis [50.46938276133494]
  Interstitial lung disease (ILD) is a leading cause of morbidity and mortality in systemic sclerosis (SSc)<n>This study introduces a novel, large-scale longitudinal chest CT analysis framework that utilizes radiomics and deep learning to predict mortality.
  arXiv  Detail & Related papers  (2025-09-27T23:46:57Z)
• Pulmonary Embolism Mortality Prediction Using Multimodal Learning Based on Computed Tomography Angiography and Clinical Data [31.830488752817804]
  The objective of this study is to implement deep learning models using Computed Tomography Angiography (CTPA), clinical data, and Pulmonary Severity Index (PESI) scores to predict PE mortality.
  arXiv  Detail & Related papers  (2024-06-03T13:10:13Z)
• Machine learning predicts long-term mortality after acute myocardial infarction using systolic time intervals and routinely collected clinical data [0.35998666903987897]
  We investigated the performance of tree-based ML algorithms to predict all-cause mortality within 14 years. Adding bPEP and bET to our feature set significantly improved the algorithms' performance. This advancement may enable better treatment prioritization for high-risk individuals.
  arXiv  Detail & Related papers  (2024-03-03T15:23:49Z)
• A new algorithm for Subgroup Set Discovery based on Information Gain [58.720142291102135]
  Information Gained Subgroup Discovery (IGSD) is a new SD algorithm for pattern discovery. We compare IGSD with two state-of-the-art SD algorithms: FSSD and SSD++. IGSD provides better OR values than FSSD and SSD++, stating a higher dependence between patterns and targets.
  arXiv  Detail & Related papers  (2023-07-26T21:42:34Z)
• Penalized Deep Partially Linear Cox Models with Application to CT Scans of Lung Cancer Patients [42.09584755334577]
  Lung cancer is a leading cause of cancer mortality globally, highlighting the importance of understanding its mortality risks to design effective therapies. The National Lung Screening Trial (NLST) employed computed tomography texture analysis to quantify the mortality risks of lung cancer patients. We propose a novel Penalized Deep Partially Linear Cox Model (Penalized DPLC), which incorporates the SCAD penalty to select important texture features and employs a deep neural network to estimate the nonparametric component of the model.
  arXiv  Detail & Related papers  (2023-03-09T15:38:16Z)
• Incremental Value and Interpretability of Radiomics Features of Both Lung and Epicardial Adipose Tissue for Detecting the Severity of COVID-19 Infection [4.772846544299196]
  Current segmentation methods do not consider positional information. The detection of COVID-19 lacks severity consideration for EAT radiomics features, which limits interpretability. This study investigates the use of radiomics features from EAT and lungs to detect the severity of COVID-19 infections.
  arXiv  Detail & Related papers  (2023-01-29T03:31:51Z)
• Electrocardiographic Deep Learning for Predicting Post-Procedural Mortality [9.192239774090208]
  Deep learning algorithm was developed to leverage waveform signals from pre-operative ECGs to discriminate post-operative mortality. Patients determined to be high risk by the deep learning model's risk prediction had an unadjusted odds ratio (OR) of 8.83 (5.57-13.20) for post-operative mortality. Findings demonstrate how a novel deep learning algorithm, applied to pre-operative ECGs, can improve discrimination of post-operative mortality.
  arXiv  Detail & Related papers  (2022-04-30T05:14:53Z)
• Controlling False Positive/Negative Rates for Deep-Learning-Based Prostate Cancer Detection on Multiparametric MR images [58.85481248101611]
  We propose a novel PCa detection network that incorporates a lesion-level cost-sensitive loss and an additional slice-level loss based on a lesion-to-slice mapping function. Our experiments based on 290 clinical patients concludes that 1) The lesion-level FNR was effectively reduced from 0.19 to 0.10 and the lesion-level FPR was reduced from 1.03 to 0.66 by changing the lesion-level cost.
  arXiv  Detail & Related papers  (2021-06-04T09:51:27Z)
• Deep Learning Predicts Cardiovascular Disease Risks from Lung Cancer Screening Low Dose Computed Tomography [23.614559487371935]
  Cancer patients have a higher risk of cardiovascular disease (CVD) mortality than the general population. LDCT for lung cancer screening offers an opportunity for simultaneous CVD risk estimation in at-risk patients. Deep learning can convert LDCT for lung cancer screening into a dual-screening quantitative tool for CVD risk estimation.
  arXiv  Detail & Related papers  (2020-08-16T21:07:01Z)
• COVID-Net S: Towards computer-aided severity assessment via training and validation of deep neural networks for geographic extent and opacity extent scoring of chest X-rays for SARS-CoV-2 lung disease severity [58.23203766439791]
  Chest x-rays (CXRs) are often used to assess SARS-CoV-2 severity. In this study, we assess the feasibility of computer-aided scoring of CXRs of SARS-CoV-2 lung disease severity using a deep learning system.
  arXiv  Detail & Related papers  (2020-05-26T16:33:52Z)
• Automated Quantification of CT Patterns Associated with COVID-19 from Chest CT [48.785596536318884]
  The proposed method takes as input a non-contrasted chest CT and segments the lesions, lungs, and lobes in three dimensions. The method outputs two combined measures of the severity of lung and lobe involvement, quantifying both the extent of COVID-19 abnormalities and presence of high opacities. Evaluation of the algorithm is reported on CTs of 200 participants (100 COVID-19 confirmed patients and 100 healthy controls) from institutions from Canada, Europe and the United States.
  arXiv  Detail & Related papers  (2020-04-02T21:49:14Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.